Log in

OTCMKTS:EMBREmbarr Downs Stock Price, Forecast & News

$0.0009
0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.00
Volume3.24 million shs
Average Volume2.74 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Embarr Downs, Inc., through its subsidiaries, engages in buying, selling, and racing thoroughbreds in the United States. It also focuses on acquiring and renovating single-family and multi-family properties. In addition, the company provides consulting services to organizations in various industries; and develops various gourmet food products. Embarr Downs, Inc. is based in San Clemente, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry Leisure
Sub-IndustryN/A
Current SymbolOTCMKTS:EMBR
CUSIPN/A
Phone+1-949-4611471

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive EMBR News and Ratings via Email

Sign-up to receive the latest news and ratings for EMBR and its competitors with MarketBeat's FREE daily newsletter.

Embarr Downs (OTCMKTS:EMBR) Frequently Asked Questions

How has Embarr Downs' stock been impacted by COVID-19 (Coronavirus)?

Embarr Downs' stock was trading at $0.0007 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EMBR shares have increased by 28.6% and is now trading at $0.0009. View which stocks have been most impacted by Coronavirus.

Has Embarr Downs been receiving favorable news coverage?

Media stories about EMBR stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Embarr Downs earned a daily sentiment score of -2.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the next few days. View the latest news about Embarr Downs.

Who are some of Embarr Downs' key competitors?

What other stocks do shareholders of Embarr Downs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Embarr Downs investors own include TOP SHIPS (TOPS), CannaRoyalty (CNNRF), Cannabics Pharmaceuticals (CNBX), Canopy Growth (CGC), Cannabis Science (CBIS), Cara Therapeutics (CARA), Bridgeline Digital (BLIN), AzurRx BioPharma (AZRX), Aphria (APHQF) and American Tower (AMT).

Who are Embarr Downs' key executives?

Embarr Downs' management team includes the following people:
  • Mr. Lane Moser, CEO, Pres, Principal Financial Officer, Principal Accounting Officer & Director

What is Embarr Downs' stock symbol?

Embarr Downs trades on the OTCMKTS under the ticker symbol "EMBR."

How do I buy shares of Embarr Downs?

Shares of EMBR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Embarr Downs' stock price today?

One share of EMBR stock can currently be purchased for approximately $0.00.

What is Embarr Downs' official website?

The official website for Embarr Downs is www.embarrdowns.com.

How can I contact Embarr Downs?

Embarr Downs' mailing address is 205 Avenida Del Mar Unit 974, SAN CLEMENTE, CA 92674-6244, United States. The company can be reached via phone at +1-949-4611471.

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.